PDF-funded researcher Natalie Kukulka (Credit-Kellie Doyle, Lake Forest College)
Parkinsonís Research Now: Surprising Treatment Options
Candy sweeteners, diabetes drugs and chemotherapy: these three items have made headlines recently as avenues for new PD treatments. After these headlines hit, PDF is often asked by our constituents, what does this mean for me? In this issue of Research Now, we interpret.
Common Natural Sweetener May Treat Parkinson's
Could a sweetener found in sugar-free candy hold potential for Parkinson's? Yes, but unfortunately it isn't as simple as eating more sweets (the drug has to be injected and needs further study), but initial results from this PDF-funded study are exciting.
Potential of Diabetes Drug for Parkinson's
Could we speed progress for Parkinson's by borrowing drugs from other disease areas? Scientists think it is possible, so they studied a drug already used for treating type 2 diabetes for its potential in Parkinson's. Their early results suggest that the drug exenatide (Byetta®) may have potential for PD.
Cancer Drug Shows Promise for Parkinson's
Another team tested a chemotherapy treatment already approved for adults with leukemia. In an early study in mice, the treatment was able to reduce levels of a-syn in the brain and improve motor symptoms. Scientists have not yet determined the drug's potential for people living with PD, but this early study offers hope.
More on PDF.org
I urge you to browse PDF's take on additional headlines at left. If you would like to update our grants team about your research, contact us at (800) 457-6676 or email@example.com.
Browse More Science News
Dr. James Beck
Director of Research Programs
Not getting these eblasts? Sign up to receive them in your inbox.
PDF's work in Parkinson's research, education and advocacy is made possible by your contributions. Make a donation today to support our mission. Thank you for your generosity.
If you have or believe you have Parkinson’s disease, then promptly consult a physician and follow your physician’s advice. This email is not a substitute for a physician’s diagnosis of Parkinson’s disease or for a physician’s prescription of drugs, treatment or operations for Parkinson’s.